eHealth (EHTH)
(Delayed Data from NSDQ)
$4.86 USD
-0.17 (-3.38%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.86 USD
-0.17 (-3.38%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Zacks News
What's in Store for Willis Towers (WLTW) in Q4 Earnings?
by Zacks Equity Research
Willis Towers' (WLTW) Q4 results are likely to reflect geographic expansion, solid segmental contributions and growth in new business.
Are You Looking for a Top Momentum Pick? Why eHealth (EHTH) is a Great Choice
by Zacks Equity Research
Does eHealth (EHTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
eHealth (EHTH) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
eHealth (EHTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
EHealth (EHTH) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does eHealth (EHTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Arthur J. Gallagher Buys Canada-Based SBW Employee Benefits
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires SBW Employee Benefits to boost its market in Atlantic Canada.
Willis Towers (WLTW) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Willis Towers (WLTW) reaches 52-week high driven by the recent agreement to acquire PE Corporate Services.
Brown & Brown Hits 52-Week High: Is Further Upside Left?
by Zacks Equity Research
Brown & Brown (BRO) touches a 52-week high on the back of recent agreement to buy Special Risk Insurance Managers.
EHealth (EHTH) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 28.33% and 29.29%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
EHealth (EHTH) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
EHealth (EHTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brown & Brown's (BRO) Unit Acquires VGW Insurance Assets
by Zacks Equity Research
Brown & Brown (BRO) acquires VGW Insurance, its second buyout in the ongoing quarter.
Arthur J. Gallagher Buys Doyle Group, Boosts Affinity Business
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of The Doyle Group to its portfolio will help enhance its Gallagher Affinity operations.
Brown & Brown's (BRO) Unit Acquires Poole Professional
by Zacks Equity Research
Brown & Brown (BRO) takes the inorganic route to achieve growth and leverage its risk management solutions.
5 Insurance Stocks Poised to Beat Q3 Earnings Estimates
by Tanuka De
We have identified five insurers poised to outshine in the third quarter banking on solid fundamentals.
Arthur J. Gallagher's Latest Buyout to Aid in Cross Selling
by Zacks Equity Research
Arthur J. Gallagher (AJG) takes the inorganic route to expand its presence and make the most of cross- selling opportunities.
Marsh & McLennan's Unit Ties Up for Pet Insurance Program
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary Marsh partners Zurich North America to launch a pet insurance program.
Arthur J. Gallagher to Acquire Michigan-Based LSG Insurance
by Zacks Equity Research
Arthur J. Gallagher (AJG) agrees to purchase LSG Insurance Partners to boost its consulting operations.
Marsh & McLennan, Xevant Tie Up to Ease Employer Assistance
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary collaborates with Xevant to offer a strategic optimization solution for employer-funded pharmacy benefit plans.
Arthur J. Gallagher (AJG) Buys Ohio-Based Andrew Insurance
by Zacks Equity Research
Arthur J. Gallagher (AJG) takes the inorganic route to improve and expand the insurance business.
Arthur J. Gallagher's Allied Insurance Buyout to Drive Growth
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Allied Insurance Brokers to boost its insurance management.
Marsh & McLennan's Unit Joins Next Peak for Cyber Protection
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary Oliver Wyman teams up with Next Peak to safeguard against cyber risks.
Arthur J. Gallagher Acquires Serna to Boost Personal Lines
by Zacks Equity Research
Arthur J. Gallagher & Co. (AJG) takes the inorganic route to improve its business in personal lines and commercial insurance products
eHealth Enters Oversold Territory
by Zacks Equity Research
eHealth has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Marsh & McLennan Inks Deal With Construction Risk Partners
by Zacks Equity Research
Marsh & McLennan (MMC) reaches an agreement with Construction Risk Partners, according to which the latter will buy the company's stock from JLT.
Is eHealth (EHTH) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
Why You Should Keep Marsh & McLennan (MMC) in Your Portfolio
by Zacks Equity Research
Banking on strategic acquisitions and financial flexibility, Marsh & McLennan (MMC) holds enough potential to reap benefits for investors.